January 1, 2020 By Brittney Guida In Announcement / NACDS 2020, San Diego, August 8 – 10, Booth 2006 Bayshore Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets USP, 500 mg and 750 mg Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity Bayshore Pharmaceuticals Announces Launch of Carvedilol Tablets
